Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zuvicin 50mg Injection

Prescription Icon
Prescription Required

Marketer

Zuventus Healthcare Ltd

Salt Composition

Epirubicin (50mg)

Overview Zuvicin 50mg Injection

Intravenous Zuvicin 50mg is indicated for treating various hematological malignancies, as well as cancers affecting the breast, stomach, lung, ovaries, and soft tissues. Post-surgical bladder cancer recurrence prevention is another application. Administered intravenously by a qualified healthcare professional via infusion, it's used alone or in conjunction with other medications within combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as improper use or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinuation should only occur under medical supervision. Zuvicin can diminish contraceptive efficacy; reliable birth control is recommended for both partners during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood work, including kidney, liver, and heart function monitoring, is essential. Prior to commencing treatment, disclose any liver or heart conditions, and provide a complete list of all medications you are currently taking, as interactions may impact Zuvicin's efficacy or mechanism. Notify your doctor if you are pregnant or lactating.

Primary Ingredients of Zuvicin 50mg Injection

No information provided. Please provide the text you wish me to rephrase.

Uses of Zuvicin 50mg Injection

Malignancy

Major Benefits of Zuvicin 50mg Injection:

This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.

Common Side effects of Zuvicin 50mg Injection:

  • Low blood platelets
  • Nausea
  • Hair loss
  • Absence of menstrual periods
  • Fever
  • Anemia (low number of red blood cells)
  • Diarrhea
  • Weight loss
  • Decreased white blood cell count (neutrophils)
  • Hot flashes
  • Gastrointestinal inflammation
  • Rash
  • Low energy
  • Eye disorder

How to use Zuvicin 50mg Injection:

Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.

How Zuvicin 50mg Injection works:

The anti-neoplastic agent, Zuvicin 50mg Injection, targets breast cancer cells. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme in DNA replication. Simultaneously, it generates cytotoxic free radicals, leading to DNA damage and ultimately, cell death, thereby hindering tumor proliferation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Zuvicin 50mg Injection with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Zuvicin 50mg Injection during pregnancy carries established risks to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might deem its use justifiable if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administering Zuvicin 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

The administration of Zuvicin 50mg Injection can induce adverse reactions that might compromise driving capabilities. Nausea and vomiting are potential side effects of Zuvicin 50mg Injection, potentially causing temporary driving impairment.

KidneyKidneySAFE IF PRESCRIBED

The use of Zuvicin 50mg Injection in patients with kidney impairment is likely safe, with current evidence indicating dose modification may be unnecessary. However, a physician's consultation is recommended. For individuals exhibiting serum creatinine levels exceeding 5 mg/dL, reduced dosages might be appropriate.

LiverLiverCAUTION

For individuals with liver impairment, the administration of 50mg Zuvicin injections requires careful consideration and potential dosage modification. Patients with severe hepatic dysfunction should avoid Zuvicin 50mg injections. A physician's consultation is advised.

What if you forget to take Zuvicin 50mg Injection :

NA

Facts to Know About Zuvicin 50mg Injection

LabelValue
Chemical Type Anthracycline Analog
Developing Habits No.
Type of Treatment Cancer Medications
Actions Cytotoxic alkaloids

FAQs on Zuvicin 50mg Injection

Yes, Zuvicin 50mg Injection is a vesicant, potentially causing skin blistering if extravasation occurs.
Zuvicin 50mg Injection treats various cancers, including breast, ovarian, stomach, lung, colorectal, and blood cancers (such as Hodgkin's and non-Hodgkin's lymphoma, leukemia, and multiple myeloma). It's also used in bladder cancer treatment and recurrence prevention after surgery, effectively inhibiting cancer cell growth.
Zuvicin 50mg Injection
1,402